Good morning, everyone. Will the meeting please come to order? I'm Mark Ordan, Chief Executive Officer and a member of the board of directors of Mednax, Inc. Due to continued public health concerns resulting from the COVID-19 pandemic and to protect the health and safety of our shareholders, directors, and employees, this year's annual meeting is being held in a virtual-only meeting format. [audio distortion] Vice President and Chief Financial Officer. Dominic Andreano, Executive Vice President, General Counsel, and Secretary for today's meeting. John C. Pepia, Senior Vice President and Chief Accounting Officer, and Dr. Mack Hinson, President, Pediatrix and Obstetrix Medical Group. Charles Lynch and Meredith Longworth will serve as inspectors for today's meeting. Notice of the meeting was given to shareholders of record on March 23rd, 2021. The record date for this meeting was March 10th, 2021. Holders of common stock on that date are entitled to one vote per share on each matter that is submitted to the company shareholders for approval. The list of shareholders of record of the company as of the close of business on March 10th, 2021, is available for inspection by the shareholders upon request. The inspectors of election have informed me that by more than a majority of the outstanding shares of common stock are present by proxy at this meeting. Therefore, a quorum is present, and I declare that this meeting is duly qualified to transact business. This meeting has been called to order to take action upon, first, the election of 11 directors to serve until the next annual meeting of shareholders or until their respective successors are duly elected and qualified. Second, a proposal to approve the amendment and restatement of the company's Amended and Restated 2008 Incentive Compensation Plan. Third, a proposal to approve the amendment and restatement of the company's 1996 Non-Qualified Employee Stock Purchase Plan as amended. Ratification of the appointment of PricewaterhouseCoopers, LLP as the company's independent registered public accounting firm for the 2021 year. The approval on an advisory basis of the compensation for the company's named executive officers as disclosed in the company's proxy statement. Finally, to consider and act upon any other business that may properly come before the meeting and any adjournments thereof. The polls are now open for you to vote. If you previously voted by proxy, you do not need to vote again. If you are voting today, you must ensure you submit your electronic ballots in order for your vote to be counted. The inspector of elections will not accept votes submitted after the closing of the polls. Please note that any votes submitted via an electronic ballot will be subject to final verification by the inspectors of elections. All shareholders attending or by proxy have now had the chance to vote, and the polls are declared closed. Inspector have provided me with a preliminary voting result. I report that the shareholders have elected all of the nominees to the board of directors, approved the amendment and restatement of the company's Amended and Restated 2008 Incentive Compensation Plan, approved the amendment and restatement of the company's 1996 Non-Qualified Employee Stock Purchase Plan as amended, ratified the appointment of PricewaterhouseCoopers as our public accounting firm, and approved the compensation of our named executive officers. Is there any other business to come before this meeting today? If there's no other business, is there a motion to adjourn this meeting? Moved. Is there a second? Second. Thank you. The business portion of the annual meeting of the shareholders of Mednax, Inc. for 2021 is now adjourned. At this time, we will be happy to answer any questions you may have. In addition to our officers and directors, please note that representatives of PricewaterhouseCoopers, LLP are attending today, and they are available to respond to appropriate questions. If you wish to ask a question, please click on the message icon on your screen. It is possible that today's meeting, including some of our comments and some of our responses to your questions, may include forward-looking statements that are based on certain assumptions and are subject to a number of risks and uncertainties, including risks and uncertainties that are included in the company's SEC reports. We assume no responsibility for updating any forward-looking statements. Are there any questions? No questions. There are no questions. At this time, if there are no other questions, this meeting is now adjourned.